Chemical prevention or reversal of cataract by phase separation inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5338545
SERIAL NO

07868288

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to methods and pharmaceutical reagents for decreasing the phase separation temperature and inhibiting the formation of high molecular weight aggregates in eye lenses, thereby inhibiting or reversing cataract formation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OCULON CORPORATIONCAMBRIDGE MA

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Clark, John I Seattle, WA 29 756
Li, Xiao-Yan Arlington, MA 6 19
Thurston, George M Belmont, MA 7 76

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation